DossierENTITY

heart drug trial

Coverage of heart drug trial in the Nexus archive.

Earliest in view: Jul 9 · 07:34 UTCMost recent: Jul 9 · 07:34 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 9 · 07:34 UTCCNBC TOP
AstraZeneca stock dives 9% after heart drug trial misses target
AstraZeneca's stock fell 9% following a heart drug trial that failed to meet its target. The decline reflects investor disappointment over the unmet clinical trial objective.